OHSU

Markus Grompe Lab Members

Craig Dorrell

Craig Dorrell Craig Dorrell received his B.Sc in Biochemistry and Biotechnology from Carleton University in Ottawa, Canada in 1993 and an M.Sc in Molecular and Medical Genetics from the University of Toronto in 1995. He remained in Toronto but moved to the laboratory of John Dick to study normal and leukemic human hematopoetic stem cells and received a Ph.D in 2003. Since joining the Grompe laboratory he has developed collections of cell type-specific monoclonal antibodies and used these to isolate and characterize cells from the mouse liver and pancreas. His current research focuses on the nature and potential of adult stem/progenitor cells from mouse and human pancreas. These are a potential source of new beta cells for the treatment of Diabetes and may be a critical target in the initiation and maintenance of pancreatic cancer.

Annelise Haft

Annelise HaftAnnelise is a Research Assistant in the Oregon Stem Cell Center. She serves as the Lead Surgical Technician and DCM liaison for a number of projects in the Grompe Lab, including the Tyrosinemia and Fanconi Anemia studies. She previously worked in the laboratory of Dr. Scott Adams at his company, Veterinary Medicine Research and Development (VMRD), doing various diagnostic assays, and background disease research.  As an undergraduate, she undertook research focusing on the differing metabolic rates of crustaceans and Apodichthys flavidus in aquatic and aerobic environments. Annelise received her Bachelor of Science degree in Biology from the University of Puget Sound in 2008, where she was a Presidential Scholar. She plans to pursue a graduate degree in Animal Behavior and Conservation Biology.

Branden Tarlow

Brandon TarlowBranden is a graduate student in the Program in Molecular and Cellular Biology (PMCB) and the joint MD-PhD program.  He grew up in Portland and got his start in biomedical research as a high school summer intern at OHSU.  He went on to earn a degree in Biological Sciences in 2004 from Stanford University where he studied regulation of hippocampal neurogenesis.  Prior to joining the MD-PhD program at OHSU, Branden spent 4 years researching tumor-associated angiogenesis at Genentech, Inc. in South San Francisco, California.  His research interests include understanding the regulation cell signalling and differentiation, the development of novel molecular and cell-based therapeutics, and translational science in general.